Skip to content

C2 Deficiency Type I C4017351

Published: July 22, 2026Updated: August 20, 2026

An immune deficiency affecting a specific complement protein. It can increase susceptibility to certain infections. Management involves infection prevention and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Neisseria meningitis

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Recurrent sinopulmonary infections

(immunologic)

Lupus-like rash

(immunologic)

Septic arthritis

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Prophylactic antibiotics

Long-term antibiotic prophylaxis to prevent recurrent bacterial infections common in complement deficiency. Choice of antibiotic based on individual infection history and sensitivities.

medication
3

Infection surveillance and immune function monitoring

Regular clinical assessment for signs of infection and monitoring of immune parameters. Prompt evaluation and treatment of any febrile illness.

monitoring

Additional treatment options

Vaccination with appropriate immunizations

Complete vaccination series including pneumococcal, meningococcal, and Haemophilus influenzae vaccines to compensate for increased infection susceptibility.

medication

Infection prevention practices

Implementation of hygiene measures, food safety practices, and avoidance of known infection exposures. Education on early signs of serious infection.

lifestyle

Immune support and general wellness optimization

Supportive measures including adequate sleep, stress management, and nutritional support to maintain overall immune competence. Supplements may be considered based on individual needs.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is C2 Deficiency Type I C4017351?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat C2 Deficiency Type I C4017351. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy